Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +48.09%
#3 Pons Pons +29.16%
#4 龙虾 (Lobster) 龙虾 (Lobster) +18.73%
#5 ADO Protocol ADO Protocol +18.06%
#6 Main Street Yield Main Street Yield +17.48%
#7 Collect on Fanable Collect on Fanable +16.65%
#8 OpenGradient OpenGradient +12.52%
#9 o1.exchange o1.exchange +12.13%
#10 Nillion Nillion +10.62%
Coin of the day
GEKKO GEKKO
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Hisse Senetlerindeki Sıralama #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Hisse Fiyatı
$0.2219522
Son senkronizasyon: 2025-09-11
Piyasa Değeri
$1.10B
Değişim (1 gün)
0.04%
Değişim (1 yıl)
0.17%
Ülke
CN
Ticaret Hubei Biocause Pharmaceutical Co., Ltd. (000627)

Kategori

Financial Services
Hubei Biocause Pharmaceutical Co., Ltd. (000627) için tedavüldeki hisse sayısı
September 2024 itibarıyla tedavüldeki hisse sayısı: 4.94B
Hubei Biocause Pharmaceutical Co., Ltd. şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 4.94B'dir. December 2022 sonunda şirketin 4.94B tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
Hubei Biocause Pharmaceutical Co., Ltd. (000627) için 2000 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
Yıl Tedavüldeki Hisse Sayısı Değiştir
2026 (TTM) 4.94B -1.45%
2023 5.01B 1.48%
2022 4.94B 0.00%
2021 4.94B 0.00%
2020 4.94B 0.15%
2019 4.93B 0.41%
2018 4.91B 11.14%
2017 4.42B 9.35%
2016 4.04B 194.28%
2015 1.37B -1.67%
2014 1.40B 3.73%
2013 1.35B 2.51%
2012 1.31B -3.09%
2011 1.36B 0.53%
2010 1.35B -0.73%
2009 1.36B 8.23%
2008 1.26B 13.94%
2007 1.10B 0.57%
2006 1.10B 86.84%
2005 586.33M -47.49%
2004 1.12B 0.00%
2003 1.12B 0.00%
2002 1.12B 90.44%
2001 586.33M 0.00%
2000 586.33M 0.00%
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
Şirket Tedavüldeki Hisse Sayısı Fark Ülke
China Life Insurance Company Limited China Life Insurance Company Limited
China Life Insurance Company Limited
601628.SS
 28.27B 472.09%
CN
AIA Group Limited AIA Group Limited
AIA Group Limited
1299.HK
 10.42B 110.92%
HK
Manulife Financial Corporation Manulife Financial Corporation
Manulife Financial Corporation
MFC.TO
 - -
CA
Fubon Financial Holding Co., Ltd. Fubon Financial Holding Co., Ltd.
Fubon Financial Holding Co., Ltd.
2881.TW
 - -
TW
MetLife, Inc. MetLife, Inc.
MetLife, Inc.
MET.US
 - -
US